SETD2 and cancer: Loss of function mutations of the tumor suppressor SET domain containing 2 (SETD2) [12], overexpression of oncogene lysine demethylase 4A (KDM4A) [13], or mutation of histone H3.3 can decrease H3K36me3 in cancer [14].